Improving cervical cancer screening in Mexico

Results from the Morelos HPV Study

Yvonne Flores, David Bishai, Eduardo Lazcano, Keerti Shah, Attila Lörincz, Mauricio Hernández, Jorge Salmerón, Daron Gale Ferris, Pilar Hernández, Mark E. Sherman, Brigitte M. Ronnett, Enrique Carmona, Alfredo Antúnez, Horacio Manzanares, Mario Uribe, Ricardo Pérez-Cuevas, Ahideé Leyva, Elsa Yunes

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Objective. The purpose of this paper is to describe some of the results of the Morelos HPV Study. The main objective of the Morelos HPV Study is to evaluate the use of human papillomavirus (HPV) DNA testing, as compared to the Papanicolaou (Pap) test, for cervical cancer (CC) screening. Material and Methods. The Morelos HPV Study is currently being conducted in Mexico, to examine the possibility of using HPV testing for CC screening. The HPV testing of self-collected vaginal and clinician-collected cervical specimens was evaluated as part of this study. The acceptability of the HPV testing of self-collected specimens was compared to that of the Pap test. A cost-effectiveness analysis (CEA) and cost-benefit analysis (CBA) was also performed. Results. The Morelos HPV Study results indicate that HPV testing has a greater sensitivity to detect cervical intraepithelial neoplasia (CIN) 2/3 and CC than the Pap test. Our results also indicate an over-all lower acceptability of the Pap test as compared to the self-collected procedure. The results of the CEA and CBA indicate that screening women between the ages of 20-80 for CC using some type of HPV testing is always more cost-effective than screening for CC using the Pap test. Conclusions. Our results suggest that self- and clinician-collected HPV testing could be used in CC prevention programs, as an effective complement or substitute for the Pap test.

Original languageEnglish (US)
JournalSalud Publica de Mexico
Volume45
Issue numberSUPPL. 3
StatePublished - Dec 1 2003

Fingerprint

Mexico
Early Detection of Cancer
Uterine Cervical Neoplasms
Papanicolaou Test
Cost-Benefit Analysis
Costs and Cost Analysis
Cervical Intraepithelial Neoplasia
DNA

Keywords

  • Cervical cancer
  • HPV testing
  • Pap
  • Screening

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Flores, Y., Bishai, D., Lazcano, E., Shah, K., Lörincz, A., Hernández, M., ... Yunes, E. (2003). Improving cervical cancer screening in Mexico: Results from the Morelos HPV Study. Salud Publica de Mexico, 45(SUPPL. 3).

Improving cervical cancer screening in Mexico : Results from the Morelos HPV Study. / Flores, Yvonne; Bishai, David; Lazcano, Eduardo; Shah, Keerti; Lörincz, Attila; Hernández, Mauricio; Salmerón, Jorge; Ferris, Daron Gale; Hernández, Pilar; Sherman, Mark E.; Ronnett, Brigitte M.; Carmona, Enrique; Antúnez, Alfredo; Manzanares, Horacio; Uribe, Mario; Pérez-Cuevas, Ricardo; Leyva, Ahideé; Yunes, Elsa.

In: Salud Publica de Mexico, Vol. 45, No. SUPPL. 3, 01.12.2003.

Research output: Contribution to journalArticle

Flores, Y, Bishai, D, Lazcano, E, Shah, K, Lörincz, A, Hernández, M, Salmerón, J, Ferris, DG, Hernández, P, Sherman, ME, Ronnett, BM, Carmona, E, Antúnez, A, Manzanares, H, Uribe, M, Pérez-Cuevas, R, Leyva, A & Yunes, E 2003, 'Improving cervical cancer screening in Mexico: Results from the Morelos HPV Study', Salud Publica de Mexico, vol. 45, no. SUPPL. 3.
Flores Y, Bishai D, Lazcano E, Shah K, Lörincz A, Hernández M et al. Improving cervical cancer screening in Mexico: Results from the Morelos HPV Study. Salud Publica de Mexico. 2003 Dec 1;45(SUPPL. 3).
Flores, Yvonne ; Bishai, David ; Lazcano, Eduardo ; Shah, Keerti ; Lörincz, Attila ; Hernández, Mauricio ; Salmerón, Jorge ; Ferris, Daron Gale ; Hernández, Pilar ; Sherman, Mark E. ; Ronnett, Brigitte M. ; Carmona, Enrique ; Antúnez, Alfredo ; Manzanares, Horacio ; Uribe, Mario ; Pérez-Cuevas, Ricardo ; Leyva, Ahideé ; Yunes, Elsa. / Improving cervical cancer screening in Mexico : Results from the Morelos HPV Study. In: Salud Publica de Mexico. 2003 ; Vol. 45, No. SUPPL. 3.
@article{bc27fcfef2254f9395113be190fe3785,
title = "Improving cervical cancer screening in Mexico: Results from the Morelos HPV Study",
abstract = "Objective. The purpose of this paper is to describe some of the results of the Morelos HPV Study. The main objective of the Morelos HPV Study is to evaluate the use of human papillomavirus (HPV) DNA testing, as compared to the Papanicolaou (Pap) test, for cervical cancer (CC) screening. Material and Methods. The Morelos HPV Study is currently being conducted in Mexico, to examine the possibility of using HPV testing for CC screening. The HPV testing of self-collected vaginal and clinician-collected cervical specimens was evaluated as part of this study. The acceptability of the HPV testing of self-collected specimens was compared to that of the Pap test. A cost-effectiveness analysis (CEA) and cost-benefit analysis (CBA) was also performed. Results. The Morelos HPV Study results indicate that HPV testing has a greater sensitivity to detect cervical intraepithelial neoplasia (CIN) 2/3 and CC than the Pap test. Our results also indicate an over-all lower acceptability of the Pap test as compared to the self-collected procedure. The results of the CEA and CBA indicate that screening women between the ages of 20-80 for CC using some type of HPV testing is always more cost-effective than screening for CC using the Pap test. Conclusions. Our results suggest that self- and clinician-collected HPV testing could be used in CC prevention programs, as an effective complement or substitute for the Pap test.",
keywords = "Cervical cancer, HPV testing, Pap, Screening",
author = "Yvonne Flores and David Bishai and Eduardo Lazcano and Keerti Shah and Attila L{\"o}rincz and Mauricio Hern{\'a}ndez and Jorge Salmer{\'o}n and Ferris, {Daron Gale} and Pilar Hern{\'a}ndez and Sherman, {Mark E.} and Ronnett, {Brigitte M.} and Enrique Carmona and Alfredo Ant{\'u}nez and Horacio Manzanares and Mario Uribe and Ricardo P{\'e}rez-Cuevas and Ahide{\'e} Leyva and Elsa Yunes",
year = "2003",
month = "12",
day = "1",
language = "English (US)",
volume = "45",
journal = "Salud Publica de Mexico",
issn = "0036-3634",
publisher = "Instituto Nacional de Salud Publica",
number = "SUPPL. 3",

}

TY - JOUR

T1 - Improving cervical cancer screening in Mexico

T2 - Results from the Morelos HPV Study

AU - Flores, Yvonne

AU - Bishai, David

AU - Lazcano, Eduardo

AU - Shah, Keerti

AU - Lörincz, Attila

AU - Hernández, Mauricio

AU - Salmerón, Jorge

AU - Ferris, Daron Gale

AU - Hernández, Pilar

AU - Sherman, Mark E.

AU - Ronnett, Brigitte M.

AU - Carmona, Enrique

AU - Antúnez, Alfredo

AU - Manzanares, Horacio

AU - Uribe, Mario

AU - Pérez-Cuevas, Ricardo

AU - Leyva, Ahideé

AU - Yunes, Elsa

PY - 2003/12/1

Y1 - 2003/12/1

N2 - Objective. The purpose of this paper is to describe some of the results of the Morelos HPV Study. The main objective of the Morelos HPV Study is to evaluate the use of human papillomavirus (HPV) DNA testing, as compared to the Papanicolaou (Pap) test, for cervical cancer (CC) screening. Material and Methods. The Morelos HPV Study is currently being conducted in Mexico, to examine the possibility of using HPV testing for CC screening. The HPV testing of self-collected vaginal and clinician-collected cervical specimens was evaluated as part of this study. The acceptability of the HPV testing of self-collected specimens was compared to that of the Pap test. A cost-effectiveness analysis (CEA) and cost-benefit analysis (CBA) was also performed. Results. The Morelos HPV Study results indicate that HPV testing has a greater sensitivity to detect cervical intraepithelial neoplasia (CIN) 2/3 and CC than the Pap test. Our results also indicate an over-all lower acceptability of the Pap test as compared to the self-collected procedure. The results of the CEA and CBA indicate that screening women between the ages of 20-80 for CC using some type of HPV testing is always more cost-effective than screening for CC using the Pap test. Conclusions. Our results suggest that self- and clinician-collected HPV testing could be used in CC prevention programs, as an effective complement or substitute for the Pap test.

AB - Objective. The purpose of this paper is to describe some of the results of the Morelos HPV Study. The main objective of the Morelos HPV Study is to evaluate the use of human papillomavirus (HPV) DNA testing, as compared to the Papanicolaou (Pap) test, for cervical cancer (CC) screening. Material and Methods. The Morelos HPV Study is currently being conducted in Mexico, to examine the possibility of using HPV testing for CC screening. The HPV testing of self-collected vaginal and clinician-collected cervical specimens was evaluated as part of this study. The acceptability of the HPV testing of self-collected specimens was compared to that of the Pap test. A cost-effectiveness analysis (CEA) and cost-benefit analysis (CBA) was also performed. Results. The Morelos HPV Study results indicate that HPV testing has a greater sensitivity to detect cervical intraepithelial neoplasia (CIN) 2/3 and CC than the Pap test. Our results also indicate an over-all lower acceptability of the Pap test as compared to the self-collected procedure. The results of the CEA and CBA indicate that screening women between the ages of 20-80 for CC using some type of HPV testing is always more cost-effective than screening for CC using the Pap test. Conclusions. Our results suggest that self- and clinician-collected HPV testing could be used in CC prevention programs, as an effective complement or substitute for the Pap test.

KW - Cervical cancer

KW - HPV testing

KW - Pap

KW - Screening

UR - http://www.scopus.com/inward/record.url?scp=9144252059&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9144252059&partnerID=8YFLogxK

M3 - Article

VL - 45

JO - Salud Publica de Mexico

JF - Salud Publica de Mexico

SN - 0036-3634

IS - SUPPL. 3

ER -